









Markets
/
Stocks
/
nasdaq-stss
/

Sharps Technology Inc

STSS

3.920USD

-0.360-8.41%

Close 11/04, 16:00（ET）Quotes delayed by 15 min

4.01MMarket Cap

LossP/E TTM



Sharps Technology Inc

3.920

-0.360-8.41%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Sharps Technology Inc

Currency: USD Updated: 2025-11-04

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very low. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Sharps Technology Inc's Score

Industry at a Glance

Industry Ranking

143 / 210

Overall Ranking

345 / 4616

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 1 analysts

Buy

Current Rating

22.000

Target Price

+414.02%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Sharps Technology Inc Highlights

StrengthsRisks

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard, and Roncadelle SafeR safety syringe product lines incorporate both active and passive safety features and have been designed to address the three primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 0.00.

Overvalued

The company’s latest PE is -0.00, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 18.46K shares, decreasing 74.83% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 12.26K shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-04

The company's current financial score is 7.32, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is robust, and its operating efficiency is low.

Score

Industry at a Glance

Previous score

7.32

Change



Financials

9.83

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

6.32

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

2.86

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.58

Key Metrics

Free cash flow

No Data

Sharps Technology Inc's Company Valuation

Currency: USD Updated: 2025-11-04

The company’s current valuation score is 8.43, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -0.00, which is -177.78% below the recent high of 0.00 and -55286783.33% above the recent low of -995.16.

Score

Industry at a Glance

Previous score

8.43

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 143/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-04

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Sharps Technology Inc is 22.00, with a high of 22.00 and a low of 22.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 1 analysts

Buy

Current Rating

22.000

Target Price

+414.02%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

110

Total

Median

Average

Company name

Ratings

Analysts

Sharps Technology Inc

STSS

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-04

The company’s current price momentum score is 1.06, which is lower than the Healthcare Equipment & Supplies industry's average of 6.77. Sideways: Currently, the stock price is trading between the resistance level at 5.89 and the support level at 2.90, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

1.09

Change

-0.03

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.048

Sell

RSI(14)

29.672

Sell

STOCH(KDJ)(9,3,3)

8.095

Oversold

ATR(14)

0.467

Low Volatility

CCI(14)

-181.847

Sell

Williams %R

96.923

Oversold

TRIX(12,20)

-1.760

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

4.414

Sell

MA10

4.752

Sell

MA20

5.182

Sell

MA50

7.460

Sell

MA100

6.559

Sell

MA200

38.162

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-04

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.39. The latest institutional shareholding proportion is 0.07%, representing a quarter-over-quarter decrease of 98.83%. The largest institutional shareholder is The Vanguard, holding a total of 12.26K shares, representing 0.05% of shares outstanding, with 1.00% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Ruemler (Timothy James)

20.22K

+0.28%

Zhang (Yuwen)

14.04K

The Vanguard Group, Inc.

Star Investors

12.26K

UBS Financial Services, Inc.

1.92K

+5718.18%

Bigger Capital Funds, LP

1.32K

Hayes (Robert Michael)

1.03K

RBC Capital Markets Wealth Management

843.00

Tower Research Capital LLC

860.00

BNP Paribas Securities Corp. North America

661.00

District 2 Capital LP

434.00

Risk Assessment

Currency: USD Updated: 2025-11-04

The company’s current risk assessment score is 1.23, which is lower than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 2.13. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.